This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prior, R. Articles by Pavlakovic, G. Search for Related Content PubMed PubMed Citation Articles by Prior, R. Articles by Pavlakovic, G.

American Journal of Pathology, Vol 148, 1749-1756, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques

R Prior, D D'Urso, R Frank, I Prikulis, S Cleven, R Ihl and G Pavlakovic
Department of Neurology, University of Dusseldorf, Germany.

Alzheimer's disease is characterized by the progressive accumulation of amyloid-beta protein (Abeta) in senile plaques and cerebral amyloid angiopathy. It is not known whether the plaque growth is a continuous and homogeneous process or whether some plaques have a more rapid evolution. As plaques grow by the deposition of Abeta, we used an in situ binding technique to analyze the deposition of fluorescein- conjugated and biotinylated Abeta1 40 and Abeta1-42 in cryosections of brains from Alzheimer's disease patients. Only a subset of senile plaques but all cerebrovascular Abeta deposits were labeled by both Abeta1-40 and Abeta1-42. Striking differences in binding were observed among adjacent plaques. Quantitative analysis showed that on average 60% of all plaques were labeled with Abeta1-42 and 31% of all plaques were labeled with Abeta1-40 (n=7; P<0.001). Confocal laser scanning microscopy of double-labeled sections revealed that the newly deposited Abeta was only partially co-localized to pre-existing Abeta and apolipoprotein E and was not co-localized to heparan sulfate proteoglycan. Abeta binding was preserved after glycolytic pretreatment with periodic acid. Our results suggest that at a given time point only a subset of active senile plaques accumulate A(beta) and that plaque growth may be conditioned by the presence of other distinct plaque components different from Abeta, apolipoprotein E or heparan sulfate proteoglycan.

This article has been cited by other articles:

				R. PRIOR, G. WIHL, and B. URMONEIT Apolipoprotein E, Smooth Muscle Cells and the Pathogenesis of Cerebral Amyloid Angiopathy: the Potential Role of Impaired Cerebrovascular A{beta} Clearance Ann. N.Y. Acad. Sci., April 1, 2000; 903(1): 180 - 186. [Abstract] [Full Text] [PDF]

				C. S. Atwood, R. D. Moir, X. Huang, R. C. Scarpa, N. M. E. Bacarra, D. M. Romano, M. A. Hartshorn, R. E. Tanzi, and A. I. Bush Dramatic Aggregation of Alzheimer Abeta by Cu(II) Is Induced by Conditions Representing Physiological Acidosis J. Biol. Chem., May 22, 1998; 273(21): 12817 - 12826. [Abstract] [Full Text] [PDF]